Our findings demonstrate that inhibition of AURKB with AZD1152, in a sequential strategy following 5-FU exposure, improves the sensitivity of CRC cells to 5-FU, and not non-malignant fibroblasts. The gene discussed is AURKB; the disease is colorectal carcinoma.